Raman Prakash (CIK 2018686) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-21). Recent activity: Buy BDTX (6,801 shares), Buy BDTX (7,907 shares), Buy BDTX (6,105 shares), Buy BDTX (4,665 shares), Buy BDTX (3,843 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 6,801 | $13,126 |
| 2026-06-22 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 7,907 | $13,126 |
| 2026-03-20 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 6,105 | $13,126 |
| 2025-12-15 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 4,665 | $12,875 |
| 2025-09-22 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 3,843 | $12,874 |
| 2025-06-20 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 5,526 | $12,876 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21